Arrowstreet Capital, Limited Partnership Adaptive Biotechnologies Corp Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $5.99 Million - $10.9 Million	-160,810 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $7.24 Million - $10.5 Million	160,810 New	160,810 $9.51 Million
Q2 2020 Aug 12, 2020	SELL	$24.95 - $48.38 $1.86 Million - $3.61 Million	-74,715 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $1.27 Million - $2.55 Million	74,715 New	74,715 $2.08 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.